Artos
ActiveAuthoring documents for life sciences in minutes, not months.
About
Artos is an AI-based document-drafting platform that helps life sciences companies turn their data into critical documents in minutes. These submissions currently take months and are the final hurdle before life sciences companies are allowed to sell their product.
Founders · 2
Josh is co-founder and CEO of Artos. Josh previously led translational AI initiatives at the University of Chicago Medicine, where he developed best-in-class AI tools for use cases ranging from clinical trial endpoint analysis to medical devices for real-time symptom management. Prior to that, Josh worked on commercial and regulatory strategy at several biotech companies. Josh has a degree in Economics from the University of Chicago.
Varun is a co-founder and CTO at Artos. He studied Molecular Engineering at the University of Chicago and has a Masters in Translational Medicine from UCSF/UC Berkeley. He previously worked as a Software Engineer in the healthcare/medtech space, where he developed ML enabled mobile applications for dementia caregivers and improved insurance infrastructure at the largest healthcare company in the world. In his free time, you can find him biking, hiking, or climbing something.
Launch
Our platform helps life sciences teams turn their data and any other information on their product into submission packages required by CMS and regulatory bodies like the FDA in half the time.
Artos provides a document-drafting platform for life sciences teams to create regulatory submission documents (e.g., INDs, PMAs) by synthesizing data from sources into first drafts in minutes, enabling rapid section iteration and secure data handling for faster submissions to agencies like the FDA.
From the original launch (Jan 2024) — may be outdated.
Formerly “Talos”
Related startups
AI for life sciences documents
AI for Pharma Intelligence
